Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertension

被引：0
|
作者：
Judd, Eric [1 ]
Jaimes, Edgar A. [2 ]
机构：
[1] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Div Nephrol, ZRB 637,1530 3rd Ave South, Birmingham, AL 35294 USA
来源：
EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2012年 / 10卷 / 03期
关键词：
aliskiren; amlodipine; angiotensin II; antihypertensive medications; cardiovascular disease; combination therapy; hypertension; renin;
D O I：
10.1586/ERC.12.7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cardiovascular-related morbidity and mortality is linked to hypertension with proportional gains in cardiovascular risk factor reduction with the lowering of blood pressure. Clinical trial data has shown that attaining goal blood pressure requires, for most patients, at least two antihypertensive medications, with a significant proportion requiring regimens of three or more medications. Single-pill triple combinations have returned to the market following results of increased efficacy and adherence over dual-and mono-therapy. The combination of aliskiren, amlodipine and hydrochlorothiazide is a rational choice for combination therapy and recent studies suggest that it is safe and effective in lowering blood pressure in patients who fail dual combination therapy.
引用
收藏
页码：293 / 303
页数：11
相关论文
共 50 条
  • [41] Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial
    Lacourciere, Yves
    Taddei, Stefano
    Konis, George
    Fang, Hui
    Severin, Thomas
    Zhang, Jack
    JOURNAL OF HYPERTENSION, 2012, 30 (10) : 2047 - 2055
  • [42] Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension
    Rakugi, Hiromi
    Tsuchihashi, Takuya
    Shimada, Kazuyuki
    Numaguchi, Hirotaka
    Nishida, Chisato
    Yamaguchi, Hiroya
    Shirakawa, Masayoshi
    Azuma, Kyoichi
    Fujita, Kenji P.
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2015, 37 (03) : 260 - 266
  • [43] Is the Combination of Benazepril and Amlodipine More Effective in Hypertension Than the Combination of Benazepril and Hydrochlorothiazide? Results of the ACCOMPLISH trial
    Preobrazhensky, D. V.
    KARDIOLOGIYA, 2009, 49 (02) : 81 - 81
  • [44] ACCOMPLISH Trial Findings: Combination Benazepril-Amlodipine or Hydrochlorothiazide is Effective for Treating Hypertension
    Weder, Alan B.
    POSTGRADUATE MEDICINE, 2009, 121 (02) : 199 - 201
  • [45] Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension
    Volpe, Massimo
    de la Sierra, Alejandro
    Ammentorp, Bettina
    Laeis, Petra
    ADVANCES IN THERAPY, 2014, 31 (05) : 561 - 574
  • [46] Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension
    Massimo Volpe
    Alejandro de la Sierra
    Bettina Ammentorp
    Petra Laeis
    Advances in Therapy, 2014, 31 : 561 - 574
  • [47] Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a subpopulation analysis of the TRINITY study
    Chrysant, Steven G.
    Izzo, Joseph L., Jr.
    Kereiakes, Dean J.
    Littlejohn, Thomas, III
    Oparil, Suzanne
    Melino, Michael
    Lee, James
    Fernandez, Victor
    Heyrman, Reinilde
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2012, 6 (02) : 132 - 141
  • [48] Efficacy of candesartan cilexetil alone or in combination with amlodipine and hydrochlorothiazide in moderate-to-severe hypertension
    MacGregor, GA
    Viskoper, JR
    Antonios, TFT
    He, FJ
    HYPERTENSION, 2000, 36 (03) : 454 - 460
  • [49] Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension
    Littlejohn, Thomas W., III
    Trenkwalder, Peter
    Hollanders, Geert
    Zhao, Yanxing
    Liao, Weichi
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 951 - 959
  • [50] COMBINATION THERAPY WITH ALISKIREN/HCTZ OR ALISKIREN/AMLODIPINE REDUCES CENTRAL SYSTOLIC BLOOD PRESSURE TO A GREATER DEGREE THAN AMLODIPINE MONOTHERAPY IN AFRICAN AMERICANS WITH STAGE 2 HYPERTENSION
    Ferdinand, K.
    Townsend, R.
    Pool, J.
    Black, H.
    Weinberger, M.
    Weitzman, R.
    Israel, M.
    Purkayastha, D.
    Izzo, J.
    ETHNICITY & DISEASE, 2010, 20 (04) : S38 - S38
12345